Key Market Indicators
The German market for Blood and Blood Forming Organs Medicine is expected to reach $5.8 billion by 2026, growing at an annual rate of 2.7%. In 2021, Germany ranked second in the world at $4.9 billion, behind Japan at $4.9 billion. Italy and South Korea were third and fourth respectively. The German anemia prevalence is expected to reach 96,430 hospital discharges by 2026, a 0.7% increase from 92,230 hospital discharges in 2021. Since 2005, German demand has grown by 0.5% each year. In 2021, Germany was ranked second in the world, behind France with 92,230 hospital discharges. The United Kingdom and Poland followed in third and fourth place.
